UK
UK
Feb-07
Endocrinology Pharmacoepidemiology
Read moreFeb-07
Endocrinology Healthcare Cost Pharmacoepidemiology
Read moreDec-06
Dec-06
Gynecology and Obstetrics Women's Health
Read moreDec-06
Endocrinology Pharmacoepidemiology
Read moreDec-06
Nov-06
Endocrinology Pharmacoepidemiology
Read moreNov-06
Endocrinology Healthcare Cost Pharmacoepidemiology
Read moreNov-06
Cardiovascular Pharmacoepidemiology
Read moreNov-06
Endocrinology Men's Health Urology
Read moreNov-06
| Date | Title | Categories | |
|---|---|---|---|
| Feb-07 | The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis | Read more | |
| Feb-07 | The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis | Read more | |
| Dec-06 | Has the Quality and Outcomes Framework (QOF) Scheme Impacted upon General Practitioners’ (GPs) Clinical Practice? | Read more | |
| Dec-06 | Hormone replacement therapy use in UK general practice: Duration, discontinuation and women’s experience | Read more | |
| Dec-06 | Risk of Diabetes Associated With Prescribed Glucocorticoids in a Large Population | Read more | |
| Dec-06 | Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile | Read more | |
| Nov-06 | An Evaluation of Diabetes Control and Reports of Hypoglycaemia in UK General Practice Following Initiation of Insulin Glargine Versus Insulin Detemir Using Observational, Real-Life Data | Read more | |
| Nov-06 | An Evaluation of the Cost of Diabetes-Related Medication Following Initiation of Treatment with Insulin Glargine Versus Insulin Detemir in the UK From Observational, Real-Life Data from General Practice | Read more | |
| Nov-06 | Antihypertensive drug budget impact of the Angiotensin II Receptor Blockers (ARB) in the UK | Read more | |
| Nov-06 | Diagnosis and Treatment of Lower Urinary Tract Symptoms, Overactive Bladder, and Benign Prostatic Hyperplasia in Men in UK General Practice | Read more | |
| Nov-06 | Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK | Read more | |
| Nov-06 | Trends in Angiotensin II Receptor Blocker (ARB) prescribing among general practitioners in the UK | Read more |
